Search Results - "TÜBERGEN, D"

Early and midterm results of radiofrequency ablation (Rafaelo® procedure) for third-degree haemorrhoids: a prospective, two-centre study by Tolksdorf, S., Tübergen, D., Vivaldi, C., Pisek, M., Klug, F., Kemmerling, M., Schäfer, H.

“…Background The aim of this study was to evaluate the safety and efficacy of radiofrequency ablation (RFA) for treating third degree haemorrhoids, with a…”
Get full text

Stent migration necessitating surgical intervention by DILLER, R, SENNINGER, N, KAUTZ, G, TÜBERGEN, D

“…Internal drainage with transhepatically or endoscopically placed endoprostheses has been used for many years as a temporary or definitive treatment for biliary…”
Get full text

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia by Smith, M, Arthur, D, Camitta, B, Carroll, A J, Crist, W, Gaynon, P, Gelber, R, Heerema, N, Korn, E L, Link, M, Murphy, S, Pui, C H, Pullen, J, Reamon, G, Sallan, S E, Sather, H, Shuster, J, Simon, R, Trigg, M, Tubergen, D, Uckun, F, Ungerleider, R

“…To define more uniform criteria for risk-based treatment assignment for children with acute lymphoblastic leukemia (ALL), the Cancer Therapy Evaluation Program…”
Get more information

Survival after relapse in childhood acute lymphoblastic leukemia: Impact of site and time to first relapse: the Children's Cancer Group Experience by GAYNON, P. S, QU, R. P, CHAPPELL, R. J, WILLOUGHBY, M. L. N, TUBERGEN, D. G, STEINHERZ, P. G, TRIGG, M. E

“…Childhood acute lymphoblastic leukemia is the single most common childhood malignancy. Despite substantial improvements in therapy, cases in which relapse…”
Get full text

Early response to therapy and outcome in childhood acute lymphoblastic leukemia a review by GAYNON, P. S, DESAI, A. A, TUBERGEN, D. G, UCKUN, F. M, BOSTROM, B. C, HUTCHINSON, R. J, LANGE, B. J, NACHMAN, J. B, REAMAN, G. H, SATHER, H. N, STEINHERZ, P. G, TRIGG, M. E

“…Early response to therapy is defined as the initial response prior to Day 28 of treatment, the conventional time of marrow evaluation. The number of reports…”
Get full text

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial by Tubergen, D G, Gilchrist, G S, O'Brien, R T, Coccia, P F, Sather, H N, Waskerwitz, M J, Hammond, G D

“…The Berlin-Frankfurt-Munster (BFM) 76/79 trial of acute lymphoblastic leukemia (ALL) in children produced impressive disease-free survival (DFS) rates with a…”
Get more information

Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia : A report from the Children's Cancer Group by UCKUN, F. M, SATHER, H. N, GAYNON, P. S, ARTHUR, D. C, TRIGG, M. E, TUBERGEN, D. G, NACHMAN, J, STEINHERZ, P. G, SENSEL, M. G, REAMAN, G. H

“…Leukemic cells from a significant number of children with acute lymphoblastic leukemia (ALL) express protein antigens characteristic of both lymphoid and…”
Get full text

Electronic photography: a new age of medical imaging? by Tübergen, D, Manegold, B C

“…This is a critical overview of present conceptions of the introduction of electronic photography in medicine. It is not a complete list of products, rather it…”
Get more information

Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study by Tubergen, D G, Krailo, M D, Meadows, A T, Rosenstock, J, Kadin, M, Morse, M, King, D, Steinherz, P G, Kersey, J H

“…Patients with lymphoblastic non-Hodgkin's lymphoma (LB NHL) were randomized to treatment with either modified LSA2L2 or ADCOMP, which added daunorubicin (DAUN)…”
Get more information

Totale Koloskopie als Screening-Methode für kolorektale Karzinome by Rijcken, E., Tübergen, D., Senninger, N.

Get full text

Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia : A joint children's cancer group and pediatric oncology branch study by BALIS, F. M, HOLCENBERG, J. S, GILCHRIST, G. S, BLEYER, W. A, POPLACK, D. G, GE, J, SATHER, H. N, MURPHY, R. F, AMES, M. M, WASKERWITZ, M. J, TUBERGEN, D. G, ZIMM, S

“…We prospectively assessed the pharmacokinetics of methotrexate, mercaptopurine, and erythrocyte thioguanine nucleotide levels in a homogenous population of…”
Get full text

Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report by Tubergen, D G, Gilchrist, G S, O'Brien, R T, Coccia, P F, Sather, H N, Waskerwitz, M J, Hammond, G D

“…This study (Childrens Cancer Group [CCG]-105) was designed in part to determine in a prospective randomized trial whether intrathecal methotrexate (IT MTX)…”
Get more information

Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors : A Pediatric Oncology Group Study by TUBERGEN, D. G, STEWART, C. F, VIETTI, T. J, PRATT, C. B, ZAMBONI, W. C, WINICK, N, SANTANA, V. M, DRYER, Z. A, KURTZBERG, J, BELL, B, GRIER, H

“…A phase I trial was conducted in children with refractory solid tumors to determine the maximum tolerated dose (MTD), dose-limiting toxicity (DLT),…”
Get full text

Blasts in CSF with a normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission: a Childrens Cancer Group study by Tubergen, D G, Cullen, J W, Boyett, J M, Gilchrist, G S, O'Brien, R T, Coccia, P F, Waskerwitz, M J

“…The Childrens Cancer Group (CCG) requires both a CSF WBC count of more than five cells per microliter and demonstration of blast cells in the cytocentrifuge…”
Get more information

Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report by Gilchrist, G S, Tubergen, D G, Sather, H N, Coccia, P F, O'Brien, R T, Waskerwitz, M J, Hammond, G D

“…This study was designed to evaluate the effect on CNS relapse (CNSR) and overall relapse rates of blast cells in the CSF containing < or = 5 cells/microL at…”
Get more information

The frequency and consequences of varicella exposure and varicella infection in children receiving maintenance therapy for acute lymphoblastic leukemia by BUDA, K, TUBERGEN, D. G, LEVIN, M. J

“…The frequency and cost of varicella and varicella exposure were determined in children receiving maintenance chemotherapy for acute lymphocytic leukemia, and…”
Get full text

Preoperative endoscopy in esophageal cancer: how accurate is it? by Colombo-Benkmann, M, Vowinkel, T, Palmes, D, Tübergen, D, Brüwer, M, Senninger, N

Get full text

Tenupodia Formation by Blasts in Bone Marrow Aspirate Smears From a Patient With Acute Monoblastic Leukemia by Bueso-Ramos, Carlos, Medeiros, L. Jeffrey, Zipf, Theodore, Nunez, Cesar, Tubergen, David

Get full text

Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment by Nachman, J, Sather, H N, Buckley, J D, Gaynon, P S, Steinherz, P G, Tubergen, D G, Lampkin, B C, Hammond, G D

“…Scant data are available on event-free survival (EFS) for young adults with leukemia who were 16-21 years of age at diagnosis. In acute lymphoblastic leukemia…”
Get more information

Assessment of drain insertion in thyroid surgery? by Tübergen, D, Moning, E, Richter, A, Lorenz, D

“…Although generally recommended the benefit of suction drains in thyroid surgery is not proven. Therefore, we started a prospective randomized trial including…”
Get more information